Dexcom

Dexcom G6^® Continuous Glucose Monitoring System (CGM)
empowers patients to better manage their diabetes and improve their outcomes.

CGM IS A REVOLUTIONARY WAY TO MANAGE DIABETES.

Dexcom CGM offers:

Real-time glucose readings on a compatible smart device*
Alerts and Alarms for patients to know when they have a hypo or hyperglycaemia event^†
Real-time data sharing with up to 5 followers^‡

A new life with zero fingersticks: the exceptional accuracy of Dexcom G6 allows patients to make treatment decisions without confirmatory fingersticks.^†

CLINICAL OUTCOMES OF DEXCOM CGM^§

In 5 clinical trials, Dexcom CGM use has proven to:

Lower HbA1c^1,2
Reduce risk of hypoglycaemia^3,4
Increase the time spent ‘in range’^1,2
Improve quality of life and well-being⁵

To know more about Dexcom CGM and its cost efficiency for the NHS, just contact us.

Call us:

0800 031 5761

Email us:

gb.sales@dexcom.com

Visit our website:

United Kingdom: www.dexcom.com/en-GB

Republic of Ireland: www.dexcom.com/en-IE

1. Beck RW, et al. DIAMOND - JAMA. 2017. 2. Soupal J et al. COMISAIR, Diabetes Technol Ther. 2016. 3. Heinemann L,et al. HypoDE, Lancet. 2018. 4. Reddy M et al. iHart CGM Diabet Med. 2018. 5. Lind M, et al. GOLD JAMA. 2017. * For a list of compatible devices, please visit dexcom.com/compatibility. † If your glucose alerts and readings from the G6 do not match symptoms or expec-tations, use a blood glucose meter to make diabetes treatment decisions. ‡ Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6® App or Receiver before making treatment decisions. § Previous CGM systems have shown to lower HbA1c. JAMA. 2017; 317(4): 371-378.

This email was distributed by Health Business Magazine

Published by Public Sector Information Ltd

Click here to unsubscribe

Call us:

Email us:

Visit our website:

©2018 Dexcom (UK) Distribution Limited LBL016336 Rev 001

©2018 Dexcom (UK) Distribution Limited
LBL016336 Rev 001